Skip to content

The Pediatric Antiretroviral Pipeline

  • Chad Cipiti

July 2015 By Polly Clayden Introduction The big news since the 2014 Pipeline Report is that there is finally a solid form of lopinavir/ritonavir (LPV/r) suitable for infants and young children. On 21 May 2015, the United States Food and…

Read more

Fit For Purpose: Antiretroviral Treatment Optimization

  • Chad Cipiti

July 2015 By Polly Clayden The most striking news since the 2014 Pipeline Report is from the START (Strategic Timing of AntiRetroviral Treatment) study.1 We now have evidence from a large, randomized, controlled trial to show that CD4 count is…

Read more

The Antiretroviral Pipeline

  • Chad Cipiti

July 2015 By Simon Collins and Tim Horn INTRODUCTION As a global community of people living with HIV, our needs from the antiretroviral (ARV) pipeline have changed considerably over the last 20 years. Antiretroviral treatment (ART), particularly for people starting treatment,…

Read more

Dedication

  • Chad Cipiti

THIS REPORT IS DEDICATED TO Tireless Champion of Disadvantaged and Vulnerable People Ana Isabel Charle (1979–2015) and Pioneering HIV Researcher and Activist Joseph Albert Marie “Joep” Lange (1954–2014)

Read more

2016 Hepatitis C Virus (HCV) Update

  • Chad Cipiti

July 15, 2016 By Mark Harrington Due to recent transitions in the TAG HCV Project [1], we did not complete a comprehensive update on hepatitis C virus (HCV) pipeline. Here are a few highlights in HCV regulation, access, and policy…

Read more

The Tuberculosis Prevention Pipeline

  • Chad Cipiti

July 15, 2016 By Mike Frick After decades of receiving short shrift from most national TB programs and international organizations, tuberculosis (TB) prevention is finally coming into the mainstream. In 2015, the World Health Organization (WHO) published its first-ever Guidelines…

Read more

The Tuberculosis Diagnostics Pipeline

  • Chad Cipiti

July 15, 2016 By Erica Lessem INTRODUCTION Over the past decade, several new options for improving TB diagnosis have become available. The past year saw considerably more progress than the previous one. However, the reality of how most TB is…

Read more
Back To Top